Affimed N.V. diskutieren
Affimed N.V.
WKN: A12BHU / Symbol: AFMD / Name: Affimed / Aktie / Biotechnologie & medizinische Forschung / Small Cap /
0,55 €
0,09 %
Buy Affimed N.V.
Affimed (NASDAQ: AFMD) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $6.00 price target on the stock.
Ratings data for AFMD provided by MarketBeat
Affimed (NASDAQ: AFMD) was downgraded by analysts at StockNews.com from a "hold" rating to a "sell" rating.
Ratings data for AFMD provided by MarketBeat
Affimed (NASDAQ: AFMD) had its "overweight" rating re-affirmed by analysts at Wells Fargo & Company. They now have a $7.00 price target on the stock.
Ratings data for AFMD provided by MarketBeat
Affimed (NASDAQ: AFMD) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $5.00 price target on the stock.
Ratings data for AFMD provided by MarketBeat
Affimed (NASDAQ: AFMD) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald. They now have a $7.00 price target on the stock.
Ratings data for AFMD provided by MarketBeat
Affimed (NASDAQ: AFMD) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald. They now have a $7.00 price target on the stock.
Ratings data for AFMD provided by MarketBeat
Affimed (NASDAQ: AFMD) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Ratings data for AFMD provided by MarketBeat
Affimed (NASDAQ: AFMD) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Ratings data for AFMD provided by MarketBeat
Affimed (NASDAQ: AFMD) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Ratings data for AFMD provided by MarketBeat
Affimed (NASDAQ: AFMD) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $5.00 price target on the stock.
Ratings data for AFMD provided by MarketBeat
Affimed (NASDAQ: AFMD) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Ratings data for AFMD provided by MarketBeat
Affimed (NASDAQ: AFMD) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Ratings data for AFMD provided by MarketBeat
Affimed (NASDAQ: AFMD) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Ratings data for AFMD provided by MarketBeat
Affimed (NASDAQ: AFMD) had its price target raised by analysts at HC Wainwright to $10.00. They now have a "buy" rating on the stock.
Ratings data for AFMD provided by MarketBeat
Affimed (NASDAQ: AFMD) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald.
Ratings data for AFMD provided by MarketBeat
Affimed (NASDAQ: AFMD) had its price target lowered by analysts at Wells Fargo & Company from $30.00 to $25.00. They now have an "overweight" rating on the stock.
Ratings data for AFMD provided by MarketBeat
Affimed (NASDAQ: AFMD) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $10.00 price target on the stock.
Ratings data for AFMD provided by MarketBeat
Affimed (NASDAQ: AFMD) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $10.00 price target on the stock.
Ratings data for AFMD provided by MarketBeat
Affimed (NASDAQ: AFMD) had its price target raised by analysts at Laidlaw from $15.00 to $25.00. They now have a "buy" rating on the stock.
Ratings data for AFMD provided by MarketBeat
Neueste Beiträge
Citigroup_Inc_ in Cheesecake Factory Inc. diskutieren